Folate: In vitro and in vivo effects on VLDL and LDL oxidation

International Journal for Vitamin and Nutrition Research

Volumn 77, Issue 1, 2007, Pages 66-72

  McEneny, Jane ^a   Couston, Claire ^a   McKibben, Bronac ^a   Young, Ian S ^a   Woodside, Jayne V ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

5 methyltetrahydrofolate; Folic acid; Ultracentrifugation; VLDL and LDL oxidation

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CELL ADHESION MOLECULE; FOLIC ACID; HOMOCYSTEINE; HYDROPEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENIC DIET; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHORESIS; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; NORMAL HUMAN; ULTRACENTRIFUGATION; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; OXIDATION-REDUCTION; TETRAHYDROFOLATES;

EID: 34248144551     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.77.1.66     Document Type: Article

References (31)

1. McCully, K. S. (1969) Vascular pathology of homocysteinaemia. Am. J. Pathology. 56, 111-128.
2. Boushey, C. J., Beresford, S. A., Omenn, G. S. and Motulsky, A.G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274, 1049-1057.
3. Wald, D. S., Law, M. and Morris, J. K. (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202-1209.
4. Homocysteine Studies Collaboration. (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288, 2015-2022.
5. Hankey, G. J. and Eikelboom, J. W. (1999) Homocysteine and vascular disease. Lancet 354, 407-413.
6. Willems, F. F., Aengevaeren, W. R., Boers, G. H., Blom, H. J. and Verheugt, F. W. (2002) Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J. Am. Coll. Cardiol. 40, 766-772.
7. Mangoni, A. A., Sherwood, R. A., Swift, C. G. and Jackson, S. H. (2002) Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial. J. Intern. Med. 252, 497-503.
8. Wilcken, D. E. L., Wang, X. L., Adachi, T., Hara, H., Duarte, N., Green, K. and Wilcken, B. (2000) Relationship between homocysteine and superoxide dismutase in homocystinuria: possible relevance to cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 20, 1199-1202.
9. Vermeulen, E. G., Niessen, H. W., Bogels, M., Stehouwer, C.D., Rauwerda, J.A. and van Hinsbergh, V.W. (2001) Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 21, 573-577.
10. Buemi, M., Marino, D., Di Pasquale, G., Floccari, F., Ruello, A., Aloisi, C., Corica, F., Senatore, M., Romeo, A. and Frisina, N. (2001) Effects of homocysteine on proliferation, necrosis, and apoptosis of vascular smooth muscle cells in culture and influence of folic acid. Thromb. Res. 104, 207-213.
11. Cook, J. W., Taylor, L. M., Orloff, S. L., Landry, G. J., Moneta, G. L. and Porter, J. M. (2002) Homocysteine and arterial disease. Experimental mechanisms. Vascul. Pharmacol. 38, 293-300.
12. Ubbink, J. B., Vermaak, W. J., van der Merwe, A., Becker, P. J., Delport, R. and Potgieter, H. C. (1994) Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J. Nutr. 124, 1927-1933.
13. Wilmink, H. W., Stroes, E. S., Erkelens, W. D., Gerritsen, W. B., Wever, R., Banga, J. D. and Rabelink, T. J. (2000) Influence of folic acid on postprandial endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 20, 185-188.
14. Nakano, E., Higgins, J. A. and Powers, H. J. (2001) Folate protects against oxidative modification of human LDL. Br. J. Nutr. 86, 637-639.
15. Joshi, R., Adhikari, S., Patro, B. S., Chattopadhyay, S. and Mukherjee, T. (2002) Free radical scavenging behaviour of folic acid: evidence for possible antioxidant activity. Free Rad. Biol. Med. 30, 1390-1399.
16. Esterbauer, H., Gebicki, J., Puhl, H. and Jurgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13, 341-390.
17. Bradley, W. A. and Gianturco, S. H. (1994) Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J. Intern. Med. 236, 33-39.
18. Resk, B. M., Haenen, G. R. M. M., van der Vijgh, W. J. F. and Bast, A. (2003) Tetrahydrofolate and 5-methyltetrahydrofolate are folates with high antioxidant activity. Identification of the antioxidant pharmacophore. FEBS Letts. 555, 601-605.
19. McEneny, J., Trimble, E. R. and Young, I. S. (1998) A simple method to assess copper-mediated oxidation of very low density lipoprotein isolated by rapid ultracentrifugation. Ann. Clin. Biochem. 35, 504-514.
20. McDowell, I. F. W., McEneny, J. and Trimble, E. R. (1995) A rapid method for measurement of the susceptibility to oxidation of low density lipoprotein. Ann. Clin. Biochem. 32, 167-174.
21. Ubbink, J. B., Vermaak, W. J. H., Bissbort, S. (1991) Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565, 441-446.
22. Wolff, S. P. (1994) Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233, 182-189.
23. Naurooz-Zadeh, J. J., Tajaddini-Sarmadi, J. and Wolff, S. P. (1994) Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Analyt. Biochem. 220, 403-409.
24. Kagan, V. E., Serbinova, E. A., Forte, T., Scita, G. and Packer, L. (1992) Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33(3), 385-397.
25. Woodside, J. V., Yarnell, J. W. G., Young, I. S., McMaster D., Gey, K. F., Patterson, C. C., Gey, K. F., Whitehead, A. S. and Evans, A. (1998) The effect of B-vitamins and antioxidant vitamins on hyperhomocysteinemia: a double blind, randomised factorial-design controlled trial. Am. J. Clin. Nutr. 67, 858-866.
26. Homocysteine Lowering Trialists Collaboration. (1998) Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials. BMJ 316, 894-898.
27. Doshi, S. N., McDowell, I. F. W., Moat, S. J., Lang, D., Newcombe, R. G., Kredan, M. B., Lewis, M. J. and Goodfellow, J. (2001) Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide? Arterioscler. Thromb. Vasc. Biol. 21, 1196-1202.
28. Moat, S. J., Hill, M. H., McDowell, I. F. W., Pullin, C. H., Ashfield-Watt, P. A. L., Clark, Z. E., Whiting, J. M., Newcombe, R. G., Lewis, M. J. and Powers, H. J. (2003) Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage. Eur. J. Clin. Nutr. 57, 483-489.
29. VITAL Trial Collaborative Group. (2003) Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J. Intern. Med. 254, 67-75.
30. Woodside, J. V., Yarnell, J. W. G., McMaster D., Young, I. S., Roxborough, H. E., McCrum, E. E., Gey, K. F. and Evans, A. (1999) Antioxidants, but not B-group vitamins increase the susceptibility of LDL to oxidation: a randomised, factorial design, placebo-controlled trial. Atherosclerosis 144, 419-427.
31. Mayer, O., Simon, J., Rosolova, R., Hromadka, M., Subrt, I. and Vobrubova, I. (2002) The effects of folate supplementation on some coagulation parameters and oxidative stress surrogates. Eur. J. Clin. Pharmacol. 58, 1-5.